Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Glutaric acidaemia type I (GA I) is an inborn error of metabolism caused by a deficiency of glutaryl-CoA dehydrogenase (GCDH) and is characterized clinically by striatal degeneration that almost always occurs in early childhood. A murine knockout model of GA I has the organic aciduria seen in the human disorder, but this model does not develop striatal degeneration spontaneously. 3-Nitropropionic acid (3NP), a succinic dehydrogenase inhibitor with specificity for the striatum, was investigated as a potential initiator of striatal degeneration in GCDH-deficient mice. This study shows that GCDH-deficient mouse pups are more susceptible to 3NP than their wild-type littermates, and that all mouse pups are more sensitive to 3NP as infants than as adolescents and adults. Increased sensitivity to 3NP early in life may model the developmental window for the striatal damage observed in human GA I.
- Al-Essa M, Bakheet S, Patay Z, et al (1998) 18Fluoro-2-deoxyglucose (18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations. Brain Dev 20: 295–301. CrossRef
- Alexi T, Hughes PE, Knusel B, Tobin AJ (1998a) Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice. Exp Neurol 153: 74–93. CrossRef
- Alexi T, Hughes PE, Faull RLM, William CE (1998b) 3-Nitropropionic acid’s lethal triplet: cooperative pathways of neurodegeneration. NeuroReport 9, R57–R64.
- Beal MF, Ferrante RJ, Henshaw R, et al (1995) 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J Neurochem 65: 919–922. CrossRef
- Bjugstad KB, Goodman SI, Freed CR (2000) Age of symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J Pediatr 137: 681–686. CrossRef
- Bjugstad KB, Zawada WM, Goodman SI, Freed CR (2001) IGF-1 and bFGF reduce glutaric and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis 24: 631–647. CrossRef
- Bogdanov MB, Ferrante RJ, Kuemmerle S, Klivenyi P, Beal MF (1998a) Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington’s disease. J Neurochem 71: 2642–2644. CrossRef
- Bogdanov MB, Ramos LE, Xu Z, Beal MF (1998b) Elevated ‘hydroxyl radical’ generation in vivo in an animal model of amylotrophic lateral sclerosis. J Neurochem 71: 1321–1324. CrossRef
- Bogdanov MB, Ferrante RJ, Mueller G, Ramos LE, Martinou JC, Beal MF (1999) Oxidative stress is attenuated in mice overexpressing BCL-2. Neurosci Lett 262: 33–36. CrossRef
- Brouillet E, Jenkins BG, Hyman BT, et al (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitroproprionic acid. J Neurochem 60: 356–359.
- Chyi T, Chang C (1999) Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience 92: 1035–1041. CrossRef
- De Mello CF, Kolker S, Ahlemeyer B, et al (2001) Intrastriatal administration of 3-hydroxyglutaric acid induces convulsion and excitotoxic lesions in rats. Brain Res 916: 70–75. CrossRef
- Flott-Rahmel B, Falter C, Schluff P, et al (1997) Nerve cell lesions caused by 3-hydroxyglutaric acid. A possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis, 20: 387–390. CrossRef
- Fox WM (1965) Reflex-ontogeny and behavioral development of the mouse. Animal Behav 13: 234–241. CrossRef
- Funk, CB, Prasad AN, Frosk P, et al (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128: 711–722. CrossRef
- Goodman SI, Biery BJ (1996) Glutaric acidemia (type 1) Ment Retard Dev Disabil Res Rev 2: 155–159.
- Goodman SI, Frerman FE (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2195–2204.
- Goodman SI, Kohlhoff JG (1975) Glutaric aciduria: inherited deficiency of glutaryl- CoA dehydrogenase activity. Biochem Med 13, 138–40.
- Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: A ‘new’ disorder of amino acid metabolism. Biochem Med 12: 12–21. CrossRef
- Gould DH, Gustine DL (1982) Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid. Neuropathol Appl Neurobiol 8: 377–393.
- Hamrick SEG, Ferriero DM (2003) The injury response in the term newborn brain: Can we neuroprotect? Curr Opin Neurol 16: 147–154. CrossRef
- Haworth JC, Booth FA, Chudley AE, et al (1991) Phenotypic variability in glutaric aciduria type 1: report of fourteen cases in five Canadian Indian kindreds. J Pediatr 118: 52–58.
- Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190, s8–s21.
- Hoffmann GF, Trefz FK, Barth PG, et al (1991) Macrocephaly: an important indication for organic acid analysis. J Inherit Metab Dis 14: 329–332. CrossRef
- Holme E, Kyllerman M, Lindstedt S (1989) Early prenatal diagnosis in two pregnancies at risk for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 12: 280–282.
- Johnson M, Perry RH, Piggott MA, et al (1996) Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging. Neurobiol Aging 17: 639–651. CrossRef
- Kim GW, Copin JC, Kawase M, et al (2000) Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid. J Cereb Blood Flow Metab 20: 119–129. CrossRef
- Kimura S, Hara M, Nezu A, Osaka H, Yamazaki S, Saitoh K (1994) Two cases of glutaric aciduria type 1: clinical and neuropathological findings. J Neurol Sci 123: 38–43. CrossRef
- Koeller DM, Woontner M, Crnic LS, et al (2002) Biochemical, pathologic, and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11: 347–357. CrossRef
- Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (1999) 3-Hydroxyglutaric and glutaric acids are neurotic through NMDA receptors in vitro. J Inherit Metab Dis, 22: 259–262.
- Kolker S, Ahlemeyer B, Krieglstein J, Hoffman GF (2000) Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-coA dehydrogenase deficiency. Pediatr Res 47: 495–503.
- Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2001) Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 50: 76–82.
- Kolker S, Kohr G, Ahlemeyer B, et al (2002) Ca2+ and Na+ dependence of 3-hydroxyglutarate-induced excitoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 52: 199–206. CrossRef
- Kolker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-coA dehydrogenase deficiency. Ann Neurol 55: 7–12. CrossRef
- Kyllerman M, Steen G (1977) Intermittently progressive dyskinetic syndrome in glutaric aciduria. Neuropediatrics 8: 397–404. CrossRef
- Kyllerman M, Skjeldal OH, Lundberg M, et al (1994) Dystonia and dyskinesia in glutaric aciduria type 1: clinical heterogeneity and therapeutic considerations. Mov Disord 9: 22–30. CrossRef
- Latini A, Borba Rosa R, Scussiato K, Llesuy S, Bello-Klein A, Wajner M (2002) 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses the antioxidant defenses in cerebral cortex of young rats. Brain Res 956: 367–373. CrossRef
- Latini A, Scussiato K, Leipnitz G, Dutra-Filho CS, Wajner M (2005) Promotion of oxidative stress by 3-hydroxyglutaric acid in rat striatum. J Inherit Metab Dis 28: 57–67. CrossRef
- Lau WK, Lui PW, Wong CK, Chan YS, Yung KK (2003) Differential expression of N-methyl-D-aspartate receptor subunit messenger ribonucleic acids and immunoreactivity in the rat neostriatum during postnatal development. Neurochem Int 43: 47–65. CrossRef
- Laurie DJ, Seeburg PH (1994) Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA. J Neurosci 14: 3180–3194.
- Lea PM IV, Faden AI (2001) Traumatic brain injury: Developmental differences in glutamate receptor response and the impact on treatment. Ment Retard Dev Dis Res Rev 7: 235–248. CrossRef
- Lund TM, Christensen E, Kristensen AS, Schousboe A, Lund AM (2004) On the neurotoxicity of glutaric, 3-hydroxyglutaric, and trans-glutaconic acids in glutaric acidemia type 1. J Neurosci Res 77: 143–147. CrossRef
- Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor JR (1999) Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 56: 60–71. CrossRef
- Peeters C, van Bel F (2001) Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn. Biol Neonate 79: 274–280. CrossRef
- Sanchez-Cabente M, Massieu L (1999) Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J Neurochem 72: 129–138. CrossRef
- Stokke O, Goodman SI, Moe PG (1976) Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and β-hydroxyglutarate: explanation of the symptoms in the glutaric aciduria? Clin Chim Acta 66: 411–415. CrossRef
- Strauss KA, Morton DH (2003) Type I glutaric aciduria, part 2: a model of acute striatal necrosis. Am J Med Genet Part C (Semin Med Genet) 121C: 53–70. CrossRef
- Stutchfield P, Edwards MA, Gray RGF, Crawley P, Green A (1985) Glutaric aciduria type 1 misdiagnosed as Leigh’s encephalopathy and cerebral palsy. Dev Med Child Neurol 27: 514–521. CrossRef
- Ullrich K, Flott-Rahmel B, Schluff. P, et al (1999) Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis 22: 392–403. CrossRef
- Urbanska EM, Blaszczak P, Saran T, Kleinrok Z, Turski WA (1998) Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol 359: 55–58. CrossRef
- Virmani A, Gaetani F, Binienda Z (2005) Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors MPTP, methamphetamine. Ann NY Acad Sci 1 053: 183–191.
- Woeffle J, Kreft B, Emons D, Haverkamp F (1996) Subdural hemorrhage as an initial sign of glutaric aciduria type 1: a diagnostic pitfall. Pediatr Radiol 26: 779–781. CrossRef
- Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity
Journal of Inherited Metabolic Disease
Volume 29, Issue 5 , pp 612-619
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department Psychiatry, University of Colorado Health Sciences Center, Denver, Colorado, USA
- 2. Department Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado, USA
- 3. Department Medicine and Division of Clinical Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado, USA